Log in or Sign up for Free to view tailored content for your specialty!
Infection News
Long COVID: Some facts, unanswered questions and implications for rheumatology – Part 2
In part two, Leonard Calabrese, DO, discusses the symptoms of long COVID and the role that rheumatologists play in diagnosing and treating patients with long COVID.
COVID-19 vaccines 87% effective at preventing hospitalization in immunosuppressed patients
Three doses of either the BNT162b2 or mRNA-1273 vaccine are 87% effective at preventing hospitalization due to COVID-19 among patients taking immunosuppressive drugs, according to data published in The Lancet Rheumatology.
Log in or Sign up for Free to view tailored content for your specialty!
Evusheld, aggressive therapy may reduce COVID-19 severity in patients on B-cell depletion
Pre-exposure prophylaxis with Evusheld, combined with aggressive outpatient treatment, may reduce COVID-19 severity in patients with immune-mediated inflammatory disease on B-cell depletion, according to a letter published in RMB Open.
FDA: Evusheld may lack efficacy against upcoming COVID-19 subvariants
Evusheld demonstrates reduced protection against the omicron subvariant BA.4.6, resulting in an increased risk for infection in those exposed to that COVID-19 strain, according to an updated FDA fact sheet.
Patients with IMIDs demonstrate lower, less durable COVID-19 vaccine response
Patients with immune-mediated inflammatory diseases demonstrate a lower, less durable COVID-19 vaccine response and are at risk for losing humoral immune protection, according to data published in The Lancet Rheumatology.
Long COVID: Some facts, unanswered questions and implications for rheumatology – Part 1
In this episode, Leonard H. Calabrese, DO, reviews the history and controversies of post-infection sequelae, as well as the facts and epidemiology of long COVID.
Approximately 1 in 8 patients with COVID-19 experience long COVID
Post-COVID, or long COVID, can develop in approximately one in eight people with COVID-19, according to data published in The Lancet.
Infections more common in patients with RA receiving tofacitinib vs TNF inhibitors
Infections are more common in patients with rheumatoid arthritis who receive tofacitinib compared with those who receive TNF inhibitors, according to data published in the Annals of the Rheumatic Diseases.
Non-bivalent COVID-19 boosters fail to protect against omicron in patients with ARDs
After a third COVID-19 vaccine dose, patients with autoimmune rheumatic diseases often fail to mount an effective response useful in preventing omicron breakthrough infection, according to data published in Annals of the Rheumatic Diseases.
Air pollution, population mobility contribute to COVID-19 mortality risk
Regional socioeconomic conditions, air pollution, population mobility and the availability of health resources are all factors that impact the risk for death attributed to COVID-19 in patients with rheumatic diseases, according to data.
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read